Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

QTTB

Q32 Bio (QTTB)

Q32 Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:QTTB
DateTimeSourceHeadlineSymbolCompany
11/12/202423:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
11/12/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
11/12/202408:05PR Newswire (US)Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development ProgramNASDAQ:QTTBQ32 Bio Inc
07/11/202423:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
07/11/202423:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTTBQ32 Bio Inc
07/11/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
07/11/202422:59PR Newswire (US)Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:QTTBQ32 Bio Inc
05/11/202422:59PR Newswire (US)Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation ConferenceNASDAQ:QTTBQ32 Bio Inc
17/10/202411:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
14/10/202421:59PR Newswire (US)Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024NASDAQ:QTTBQ32 Bio Inc
11/10/202407:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
28/09/202411:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
28/09/202411:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
28/09/202411:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
28/09/202411:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
29/08/202420:59PR Newswire (US)Q32 Bio to Participate in Upcoming September Investor ConferencesNASDAQ:QTTBQ32 Bio Inc
15/08/202406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
08/08/202421:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
08/08/202421:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTTBQ32 Bio Inc
08/08/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
09/07/202421:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
09/07/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
09/07/202420:59PR Newswire (US)Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic DermatitisNASDAQ:QTTBQ32 Bio Inc
01/07/202420:59PR Newswire (US)Q32 Bio Joins Russell 3000® IndexNASDAQ:QTTBQ32 Bio Inc
01/06/202406:25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QTTBQ32 Bio Inc
09/05/202421:26Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
09/05/202421:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTTBQ32 Bio Inc
09/05/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
09/05/202420:59PR Newswire (US)Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:QTTBQ32 Bio Inc
03/04/202422:00PR Newswire (US)Q32 Bio Appoints Lee Kalowski as President & Chief Financial OfficerNASDAQ:QTTBQ32 Bio Inc
 Showing the most relevant articles for your search:NASDAQ:QTTB